Macro Array Diagnostics was selected as the only Austrian life science company to receive 2.5 Mio € within the EU’s Horizon 2020 (small- and medium enterprise) funding programme. This is the highest amount of EU funding any Austrian company has ever received. We are very happy and proud about this success in a highly selective application and review process.

The funds will be used to speed up the development of the revolutionary ALEX^® – Allergy Explorer test platform and to develop an automated processing solution for medical laboratories.

Read the full press release here. For information on the H2020 Funding program visit here and here.

Among 30 participating companies, MADx was chosen by the jury of the Best of Biotech (BoB) award as one of the most promising start-up companies in 2017.

The prestigious BoB award is funded by industry giants like Roche or Shire and supported by the Austrian Federal government. (http://www.bestofbiotech.at).

Thanks to all who visited our booth and our poster presentation at the ISMA in Luxembourg this year.

For all who are interested in the poster about the CCD antibody blocking capabilities of ALEX, please click here to download.

See you at the EAACI 2018 in Munich!

We are happy to announce that from now on we offer the MADx custom array service. To support your research endeavours, we offer to produce arrays of selected ALEX allergens combined with your own allergen preparations.

If you are interested in the custom array service, please contact us.

We are happy to announce that the Allergy Explorer (ALEX®) test kit is now CE marked and available as an IVD product.

ALEX is the first in vitro multiplex allergy test that offers:

• Simultaneous measurement of total and specific IgE
• A near complete allergen panelIntegrated CCD inhibition
• Flexible software to create on-demand allergen panel